Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion type Assertion NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_head.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion description "[Gene mutations of KIT or PDGFRA are critical in GISTs, because the aberrant versions not only are correlated with the specific cell morphology, histologic phenotype, metastasis, and prognosis, but also are the targets of therapy with imatinib and other agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion evidence source_evidence_literature NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion SIO_000772 18671247 NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion wasDerivedFrom befree-20140225 NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.
- NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_assertion wasGeneratedBy ECO_0000203 NP231252.RAob6UGXmgIfmj9WPlFt0alQR1eYRVXJvgoV7RAgnSQy4130_provenance.